| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/04/2002 | CN1366909A Nano bovine bezoar anti-inflammatory preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366908A Nano Jianbu preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366907A Nano Jianmin throat-benefiting preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366906A Nano blood sugar-reducing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366905A Nano jueming blood-fat-reducing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366904A Nano drool-controlling preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366903A Nano lung-benefiting preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366902A Nano heart-benefiting preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366901A Nano liyanling preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366900A Nano lingbao huxin preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366899A Nano dizziness-clearing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366898A Nano jizhi preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366897A Nano hemp seed preparation and preparation method thereof |
| 09/04/2002 | CN1366896A Nano hemp intestine-moistening preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366895A Nano supplement both qi and blood preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366894A Nano lung-clearing anti-inflammatory preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366893A Nano qingfei yihuo preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366892A Nano qinghouyan preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366891A Nano clear and quiet preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366890A Nano clear heat and resolve toxin preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366889A Nano liyan jiedu preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366888A Nano quicken the blood and disperse welling abscess preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366887A Nano amber dragon-embracing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366880A Sophorcarpidine alkaloid and decongestant compound medicine and its preparation method |
| 09/04/2002 | CN1366878A Texture screening granules containing active components |
| 09/04/2002 | CN1366877A Chinese medicine volatile self-emulsification medicine-releasing system |
| 09/04/2002 | CN1090187C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090186C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090029C Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 09/04/2002 | CN1090028C Medicine for treatment of restenosis and arteriosclerosis |
| 09/04/2002 | CN1090019C 组合物 The composition |
| 09/04/2002 | CN1090018C Extended release formulation |
| 09/04/2002 | CN1090017C Controlled release formulation for water soluble drugs in which passageway is formed in situ |
| 09/04/2002 | CN1090016C Process for preparing silicone elastomer compositions |
| 09/04/2002 | CN1090013C Hair conditioning compositions |
| 09/03/2002 | US6444859 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
| 09/03/2002 | US6444797 Chitosan microflake and method of manufacturing the same |
| 09/03/2002 | US6444791 Therapy for vision defects; administering macroglobulins |
| 09/03/2002 | US6444748 Preparing aqueous polymer dispersions |
| 09/03/2002 | US6444710 Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions |
| 09/03/2002 | US6444689 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 09/03/2002 | US6444660 Dexamethasone covalently bonded to a lipid moiety via a linking group |
| 09/03/2002 | US6444447 Polymer grafting by polysaccharide synthases |
| 09/03/2002 | US6444418 Plasma-like solution |
| 09/03/2002 | US6444261 A particulate carrier for carrier-bound reactions, detection and/or isolation processes; used for immunoassay markers to bond a solid core by means of biopolymers to an affinity component; particles with usable properties, e.g. marking |
| 09/03/2002 | US6444234 Liquid carriers |
| 09/03/2002 | US6444232 Aqueous suspension |
| 09/03/2002 | US6444227 Radiation or enzyme crosslinked gelatin |
| 09/03/2002 | US6444226 Purification and stabilization of peptide and protein pharmaceutical agents |
| 09/03/2002 | US6444225 Bioavailability;melting, solidification |
| 09/03/2002 | US6444223 Fineness particle size; sustained release of drug |
| 09/03/2002 | US6444220 Topical applying |
| 09/03/2002 | US6444218 Soft chewable multivitamin tablet comprising separated active ingredients |
| 09/03/2002 | US6444217 Drug delivery devices, and methods of use |
| 09/03/2002 | US6444200 Interferon and one fatty acid moiety covalently attached to the cytokine that enhances cutaneous delivery; treating infections or enhancing an immune response |
| 09/03/2002 | US6444198 Effervescent laxatives |
| 09/03/2002 | US6444193 Process for preparation of gas containing vesicles |
| 09/03/2002 | US6444033 Article comprising a diffuser with flow control features |
| 09/03/2002 | US6443949 Method of drug delivery to interstitial regions of the myocardium |
| 09/03/2002 | US6443898 Therapeutic delivery systems |
| 09/03/2002 | CA2145646C Phase-separated membrane |
| 09/03/2002 | CA2096841C Drug delivery porphyrin compositions and methods |
| 09/03/2002 | CA2079934C Taste mask coatings for preparing chewable pharmaceutical tablets |
| 09/03/2002 | CA2060289C Antiplaque oral compositions |
| 09/03/2002 | CA2055255C Process for preparing neotrehalose and its uses |
| 09/02/2002 | CA2374257A1 Inhalatory compositions of formoterol |
| 09/01/2002 | CA2356201A1 Compounds and compositions for delivering active agents |
| 08/29/2002 | WO2002066668A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same |
| 08/29/2002 | WO2002066490A2 Cationic sterol derivatives, ph-sensitive liposomes comprising cationic sterol derivatives and method for loading liposomes with active substances |
| 08/29/2002 | WO2002066489A2 Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
| 08/29/2002 | WO2002066078A2 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066077A2 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066070A1 Pharmaceutical compositions containing decoy and method of using the same |
| 08/29/2002 | WO2002066058A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | WO2002066031A1 Utilization of buprenorphine in urinary incontinence therapy |
| 08/29/2002 | WO2002066026A2 Tramadol-based medicament |
| 08/29/2002 | WO2002066025A2 Combination of active ingredients consisting of the racemate of tramadol and of (+)-o-desmethyltramadol |
| 08/29/2002 | WO2002066022A1 Retinoid hepatitis therapy |
| 08/29/2002 | WO2002066018A2 Transdermal therapeutic system containing testosterone and method for the production thereof |
| 08/29/2002 | WO2002066017A1 Liothyronine sodium and levothyroxine sodium combination |
| 08/29/2002 | WO2002066016A2 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
| 08/29/2002 | WO2002066015A1 Use of polyalkylamine polymers in controlled release devices |
| 08/29/2002 | WO2002066014A2 Cubic liquid crystalline compositions and methods for their preparation |
| 08/29/2002 | WO2002066013A2 Liposome-mediated dna administration |
| 08/29/2002 | WO2002066012A2 Amphoteric liposomes and the use thereof |
| 08/29/2002 | WO2002066011A1 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066010A1 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066009A1 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066008A1 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066007A1 Gel emulsions in the form of o/w emulsions having a hydrocolloid content |
| 08/29/2002 | WO2002066006A1 Sustained-release suspension of ceftiofur hydrochloride |
| 08/29/2002 | WO2002066005A1 Composition and method for controlled release injections |
| 08/29/2002 | WO2002066004A1 Compositions with controlled drug release |
| 08/29/2002 | WO2002066003A1 Composition for use in electroporation |
| 08/29/2002 | WO2002066002A2 Pharmaceutical formulation |
| 08/29/2002 | WO2002066000A2 Novel cosmetic slimming compositions containing boldine |
| 08/29/2002 | WO2002065994A1 Cosmetics and process for producing cosmetics |
| 08/29/2002 | WO2002065991A2 Divalproex sodium tablets |
| 08/29/2002 | WO2002065983A2 Hair covering with conditioner |
| 08/29/2002 | WO2002065981A2 Chemotherapeutic composition using calcium phosphate paste |